TiumBio Co., Ltd. (KOSDAQ:321550)
South Korea · Delayed Price · Currency is KRW 6,210.00
0.00 (0.00%)
At close: Jun 5, 2026
TiumBio Market Cap
TiumBio has a market cap or net worth of 186.54 billion as of June 8, 2026. Its market cap has increased by 13.36% in one year.
Market Cap
186.54B
Enterprise Value
190.65B
Revenue
13.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,210.00
Market Cap Chart
Since November 22, 2019, TiumBio's market cap has decreased from 311.90B to 186.54B, a decrease of -40.19%. That is a compound annual growth rate of -7.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 186.54B | 9.35% |
| Dec 30, 2025 | 170.58B | 51.78% |
| Dec 30, 2024 | 112.39B | -53.28% |
| Dec 28, 2023 | 240.56B | -20.51% |
| Dec 29, 2022 | 302.63B | -34.44% |
| Dec 30, 2021 | 461.60B | -7.09% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kangstem Biotech | 247.83B |
| Y-Biologics | 225.39B |
| NIBEC | 221.56B |
| Genome & Company | 195.98B |
| ViGenCell | 194.74B |
| Bio Solution | 180.37B |
| Ensol Biosciences | 172.98B |
| ABION | 158.85B |